Board Certification: 

American Board of Internal Medicine, Subspecialty Board of Rheumatology

Education: 

Dr. Krajcer earned a medical degree from the University of Texas Medical School at Houston and completed an internal medicine residency at the University of Arizona Department of Medicine, Tucson Hospitals.  He completed a fellowship in rheumatology and clinical immunology at the University of Texas Health Sciences Center, in San Antonio.

Special Interests:

Dr. Krajcer diagnoses and manages inflammatory, auto-immune, and degenerative musculoskeletal diseases in adults.  His specific areas of interest include inflammatory arthritis, inflammatory muscle diseases, systemic lupus erythematosus, mixed-connective tissue disease, and scleroderma.  He is also interested in the use of ultrasound in the evaluation and management of joint disease as it pertains to rheumatology.

Practice Philosophy:

“I believe that the patient and I work together towards the best possible outcome as a team.  This involves listening carefully, making sure the patient is well informed, and after reviewing all available options, choosing a treatment plan together with the patient.  I provide patients with the tools necessary to remain active participants in their own care.” 

Clinical Research

A Study to Evaluate the Efficacy and Safety of a new treatment for Systemic Lupus Erythematosus (SLE)

Principal Investigator: Anthony Krajcer, MD 
Study Coordinator: Michelle Harder 
Phone: 206-860-4761
Email: michelle.harder@polyclinic.com

A Study to assessing the clinical benefit of SAR153191 on top of methotrexate in patients with active rheumatoid arthritis (RA) who have failed previous tumor necrosis factor-alpha (TNF-α) antagonists

Principal Investigator: Anthony Krajcer, MD 
Study Coordinator: Michelle Harder 
Phone: 206-860-4761
Email: michelle.harder@polyclinic.com